Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Seer Inc SEER

Technology Scientific & Technical Instruments
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution... see more

Recent & Breaking News (NDAQ:SEER)

Seer Announces Pricing of Upsized Public Offering of Common Stock

GlobeNewswire January 27, 2021

Seer Announces Proposed Public Offering of Common Stock

GlobeNewswire January 25, 2021

Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics

GlobeNewswire January 11, 2021

Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics

GlobeNewswire January 11, 2021

Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 4, 2021

Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire December 8, 2020